Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation
NCT ID: NCT07113769
Last Updated: 2025-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
130 participants
OBSERVATIONAL
2025-08-01
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China
NCT04956497
Plethysmographic Waveform for Monitoring the Quality of Cardiopulmonary Resuscitation
NCT01987245
The Critical Threshold of Pulse Oximetry Plethysmographic Waveform Parameters in High Quality CPR
NCT03754946
ON-SCENE Initiation of Extracorporeal CardioPulmonary Resuscitation During Refractory Out-of-Hospital Cardiac Arrest
NCT04620070
Research on Key Technologies and System Optimization of Early Warning and Resuscitation of Cardiac Arrest
NCT04955288
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CA patients who have fully recovered after receiving ECPR treatment
No interventions assigned to this group
CA patients with organ dysfunction after receiving ECPR treatment
No interventions assigned to this group
CA patients who died or suffered brain death after receiving ECPR treatment
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The cardiac arrest is witnessed, and bystanders perform traditional cardiopulmonary resuscitation (CPR), and the time interval from the occurrence of cardiac arrest to the start of traditional CPR is no more than 5 minutes.
3. The causes of cardiac arrest are reversible, such as cardiogenic, pulmonary embolism, severe hypothermia, drug poisoning, trauma, acute respiratory distress syndrome, etc.
4. After 20 minutes of traditional CPR, there is no restoration of spontaneous circulation or hemodynamic instability, or the restoration of spontaneous circulation occurs, but the spontaneous heart rhythm cannot be maintained.
5. The informed consent has been signed.
Exclusion Criteria
2. Hematological diseases, such as hematological malignancies, aplastic anemia, idiopathic thrombocytopenic purpura (ITP), etc.
3. Malignant tumors in other systems except the hematological system.
4. Patients who have received massive plasma or platelet transfusions during hospitalization or recently.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Henan Provincial People's Hospital
OTHER
Central China Fuwai Hospital of Zhengzhou University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jianchao, Li
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fuwai Central China Cardiovascular Hospital
Zhengzhou, Henan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ljc2025 No.12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.